STOCK AWARDS: Mr. Culp receives equity grants every three years, the most recent of which was in 2006. OPTION AWARDS: Mr. Culp receives equity grants every three years, the most recent of which was in 2006.
Base Salary
$1,100,000
Cash Bonus
$3,267,250
Stock Gains
Stock Expense
Stock Granted
$0$0$8,841,548
Options Gains
Options Expense
Options Granted
$0$2,267,616$6,734,142
Other
$580,225
FYE 12/31/2008
Biography
H. Lawrence Culp, Jr., 46, President and Chief Executive Officer of Danaher since May 2001; director of GlaxoSmithKline plc.
Board Memberships
Danaher Member of the Board of Directors
Former Named Executive Positions
N/A
Former Board Affiliations
GlaxoSmithKline Member of the Board of Directors
Accumulated Wealth
Total
$108,362,180
Equity Holdings
$99,792,147
Pension Balance
$40,335
Deferred Comp. Balance
$8,529,698
H. Lawrence Culp Jr. Danaher (DHR)
Danaher
Executives
Subscribers only. Login to view all executives and board members H. Lawrence Culp Jr. works with. Not a subscriber? Click here for more information.
Board Members
Subscribers only.
H. Lawrence Culp Jr. Danaher (DHR)
Danaher
General Information
Subscribers only. Login for a break-down of board compensation for H. Lawrence Culp Jr. Not a subscriber? Click here for more information.
Annual Board Compensation
Subscribers only.
H. Lawrence Culp Jr. Danaher (DHR)
Danaher
Title
Securities
Date
Price
Grant Date Stock Price
Date Exercisable
Subscribers only. Login to view recent equity awards for H. Lawrence Culp Jr. Not a subscriber? Click here for more information.
H. Lawrence Culp Jr. Danaher (DHR)
Danaher
Title
Individual Specific
Date
Subscribers only. Login to view all 8-K filings with updates for H. Lawrence Culp Jr. Not a subscriber? Click here for more information.
